Vifor Fresenius Medical Care Renal Pharma Danmark A/S — Credit Rating and Financial Key Figures

Vifor Fresenius Medical Care Renal Pharma Danmark A/S (CVR number: 36694424) is a company from KØBENHAVN. The company reported a net sales of 1.7 mDKK in 2017, demonstrating a decline of -54.2 % compared to the previous year. The operating profit percentage was at 1.6 % (EBIT: 0 mDKK), while net earnings were 8.9 kDKK. The profitability of the company measured by Return on Assets (ROA) was 2.2 %, which can be considered weak and Return on Equity (ROE) was 1.4 %, which can be considered weak. The equity ratio, a key indicator for solidity, stood at 91.6 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. Vifor Fresenius Medical Care Renal Pharma Danmark A/S's liquidity measured by quick ratio was 11.9 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.